ORBIT II trial met primary endpoints treating patient population in which 99.3% of subjects had severely calcified lesions 30-day freedom from MACE... ...http://www.asianhhm.com/press/pressrelease_archives.asp?PID=4634&title=Cardiovascular-Systems-Presents-New-LateBreaking-Coronary-Results-at-EuroPCR-Conference
The significance of heredity for common forms of atherosclerotic disease was mapped by researchers at Lund University in Sweden. No studies have... ...http://feedproxy.google.com/~r/allhealthnews/~3/a2qpqx12rtE/nationwide-study-maps-atherosclerotic-disease-heredity-119321-1.htm
1 comments | 22/05/2013 12:39 PM | The sun teaches two important lessons: it does not make any difference and shines on everyone, rich or poor... ...http://moneylife.in/article/sunlight-the-be-all-and-end-all-of-human-health/32817.html
Synageva BioPharma Corp. (Synageva) has announced that the US Food and Drug Administration (FDA) granted Breakthrough Therapy designation to... ...http://www.pharmabiz.com/NewsDetails.aspx?aid=75464&sid=2
- Use of Corus® CAD Led to a Statistically Significant Reduction in Additional Cardiac Testing - PR Newswire PALO ALTO, Calif., May 20, 2013... ...http://www.asianhhm.com/news/news_archives.asp?NewsID=45676&title=CardioDx-Announces-Publication-of-the-IMPACTCARD-Trial-Demonstrating-Use-of-Corus®-CAD-Test-Influenced-Cardiologistsapos-Clinical-Management-of-Patients-with-Symptoms-Suggestive-of-Obstruc
The world is inundated on examples of...